Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:8290963.
doi: 10.1155/2016/8290963. Epub 2016 Oct 27.

Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems

Piyush Mehta  1
Affiliations
Review

Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems

Piyush Mehta. J Drug Deliv. 2016.

Abstract

Administration of drug molecules by inhalation route for treatment of respiratory diseases has the ability to deliver drugs, hormones, nucleic acids, steroids, proteins, and peptides, particularly to the site of action, improving the efficacy of the treatment and consequently lessening adverse effects of the treatment. Numerous inhalation delivery systems have been developed and studied to treat respiratory diseases such as asthma, COPD, and other pulmonary infections. The progress of disciplines such as biomaterials science, nanotechnology, particle engineering, molecular biology, and cell biology permits further improvement of the treatment capability. The present review analyzes modern therapeutic approaches of inhaled drugs with special emphasis on novel drug delivery system for treatment of various respiratory diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Advantages and challenges in novel respiratory drug deliveries.
See this image and copyright information in PMC

References

    1. Winkler J., Hochhaus G., Derendorf H. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proceedings of the American Thoracic Society. 2004;1:356–363. doi: 10.1513/pats.200403-025ms. - DOI - PubMed
    1. Al-Hallak M. K., Sarfraz M. K., Azarmi S., Roa W. H., Finlay W. H., Löbenberg R. Pulmonary delivery of inhalable nanoparticles: dry powder inhalers. Therapeutic Delivery. 2011;2(10):1313–1324. doi: 10.4155/tde.11.100. - DOI - PubMed
    1. Healy A. M., Amaro M. I., Paluch K. J., Tajber L. Dry powders for oral inhalation free of lactose carrier particles. Advanced Drug Delivery Reviews. 2014;75:32–52. doi: 10.1016/j.addr.2014.04.005. - DOI - PubMed
    1. Hoppentocht M., Hagedoorn P., Frijlink H. W., de Boer A. H. Technological and practical challenges of dry powder inhalers and formulations. Advanced Drug Delivery Reviews. 2014;75:18–31. doi: 10.1016/j.addr.2014.04.004. - DOI - PubMed
    1. Liu X., Huang G. Formation strategies, mechanism of intracellular delivery and potential clinical applications of pH-sensitive liposomes. Asian Journal of Pharmaceutical Sciences. 2013;8(6):319–328. doi: 10.1016/j.ajps.2013.11.002. - DOI